Search Results 441-450 of 24158 for prostate cancer

  1. cancer survivorship Archives - Mayo Clinic News Network

    what the survivor might experience based on the type of cancer. For example, both prostate cancer and its treatment can cause urinary incontinence and erectile ...

  2. Dr. Matthew Tollefson Archives - Mayo Clinic News Network

    prostate cancer diagnosed in 2024, according to the American Cancer Society. Treatments vary, including chemotherapy, hormone therapy, ablative therapy, ...

  3. Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy in Prostate Carcinoma - Mayo Clinic

    ... prostate cancer recurrence after RT. Serum CgA level is measured before the start of RT and/or the start of neoadjuvant ADT for patients undergoing a ...

  4. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer - Mayo Clinic

    The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate cancer who received at ...

  5. Testing Whether The Addition Of Carboplatin Chemotherapy To Cabazitaxel Chemotherapy Will Improve Outcomes Compared To Cabazitaxel Alone In People With Castrate-Resistant Prostate Cancer That Has Spread Beyond The Prostate To Other Parts Of The Body - Mayo Clinic

    Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.

  6. Prostatitis Often Challenging to Diagnose - Mayo Clinic News Network

    A lot of men are familiar with certain prostate-related problems, such as the risk of prostate enlargement and prostate cancer. ... prostate gland, which is ...

  7. A Study of Single Patient Investigational Drug CPI-613 for Use in Treatment-Refractory, Metastatic Prostate Cancer - Mayo Clinic

    About this study. This is a single patient study of an investigational drug CPI-613 for treatment of metastatic prostate cancer. Participation eligibility.

  8. Publications - Sarah E. James, M.D., Ph.D. - Mayo Clinic

    ... prostate cancer patients. Cancer Epidemiol. 2025 Apr; 95:102769 Epub 2025 Feb 12. View PubMed; Yap JQ, Riggan KA, Cobran EK, Halyard MY, James SE, Kelly MK ...

  9. Diarrhea: Cancer-related causes and how to cope - Mayo Clinic

    Changes in your diet may help ease cancer-related diarrhea. If those don't help, medications are available.

  10. Abiraterone, micronized (oral route) - Mayo Clinic

    Abiraterone is used in combination with methylprednisolone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is ...